CytoMed Therapeutics Ltd (GDTC)
2.24
+0.02
(+0.90%)
USD |
NASDAQ |
Nov 14, 16:00
2.24
0.00 (0.00%)
After-Hours: 18:02
CytoMed Therapeutics Enterprise Value: 21.16M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 21.16M |
| November 12, 2024 | 21.71M |
| November 11, 2024 | 23.12M |
| November 08, 2024 | 22.20M |
| November 07, 2024 | 24.86M |
| November 06, 2024 | 23.70M |
| November 05, 2024 | 25.82M |
| November 04, 2024 | 24.20M |
| November 01, 2024 | 22.14M |
| October 31, 2024 | 23.36M |
| October 30, 2024 | 21.23M |
| October 29, 2024 | 22.55M |
| October 28, 2024 | 25.09M |
| October 25, 2024 | 27.97M |
| October 24, 2024 | 30.51M |
| October 23, 2024 | 28.66M |
| October 22, 2024 | 24.86M |
| October 21, 2024 | 21.16M |
| October 18, 2024 | 21.16M |
| October 17, 2024 | 20.13M |
| October 16, 2024 | 19.55M |
| October 15, 2024 | 19.55M |
| October 14, 2024 | 20.47M |
| October 11, 2024 | 19.09M |
| October 10, 2024 | 18.74M |
| Date | Value |
|---|---|
| October 09, 2024 | 18.74M |
| October 08, 2024 | 19.32M |
| October 07, 2024 | 19.72M |
| October 04, 2024 | 17.51M |
| October 03, 2024 | 15.90M |
| October 02, 2024 | 16.20M |
| October 01, 2024 | 14.47M |
| September 30, 2024 | 13.66M |
| September 27, 2024 | 13.43M |
| September 26, 2024 | 12.62M |
| September 25, 2024 | 12.51M |
| September 24, 2024 | 12.39M |
| September 23, 2024 | 13.08M |
| September 20, 2024 | 13.43M |
| September 19, 2024 | 13.43M |
| September 18, 2024 | 13.66M |
| September 17, 2024 | 13.95M |
| September 16, 2024 | 12.85M |
| September 13, 2024 | 12.85M |
| September 12, 2024 | 12.74M |
| September 11, 2024 | 13.20M |
| September 10, 2024 | 14.24M |
| September 09, 2024 | 12.63M |
| September 06, 2024 | 12.62M |
| September 05, 2024 | 12.74M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
12.28M
Minimum
Aug 26 2024
57.67M
Maximum
Jul 11 2023
27.56M
Average
30.29M
Median
Enterprise Value Benchmarks
| EUDA Health Holdings Ltd | 160.01M |
| Raffles Medical Group Ltd | 1.078B |
| Haw Par Corp Ltd | -539.71M |
| WAVE Life Sciences Ltd | 1.803B |
| Mobile-health Network Solutions | 5.868M |
Enterprise Value Related Metrics
| Earnings Yield | -8.63% |